Litcius/Paper detail

EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma

Mir Lim, Joseph W. Franses, Robin John Lester Imperial, Umair Majeed, Jill Tsai, David Hsiehchen

2023Gastroenterology23 citationsDOIOpen Access PDF

Topics & Concepts

LenvatinibHepatocellular carcinomaScopusMedicineOncologyCancer researchInternal medicineBioinformaticsBiologyMEDLINESorafenibBiochemistryCancer Genomics and DiagnosticsHepatocellular Carcinoma Treatment and PrognosisPancreatic and Hepatic Oncology Research
EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma | Litcius